• About us
• Contact

Advertisement

Organisation › Details

Primerdesign Ltd. (Primer Design)

Primerdesign is a spinoff company from the University of Southampton specialising in Real-Time PCR technology. As well as solving challenging problems for researches they also manufacture an extensive range of 'genesig' pathogen and disease testing kits. Furthermore the genesig range has animal speciation kits which were in high demand during the 2013 horse-meat scandal. Finally in 2009 Primerdesign were the first company in the world to develop a detection kit for H1N1 swine flu. *

 

	Start	2005-01-01 splitoff
	Group	Novacyt (Group)
	Predecessor	University of Southampton
	Industry	genesig® q16 real-time PCR system
	Industry 2	real-time PCR technology
	Person	Wicks, Jim (PrimerDesign Ltd 201201 Managing Director)
	Region	Southampton, Hampshire
	Country	United Kingdom (GB)
	Street	Nursling Street The Mill Yard, Rownhams
	City	SO16 0AJ Southampton, Hampshire
	Tel	+44-23-8074-8830
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Novacyt (Group)

• [1] Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited  (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]"....
• [2] Novacyt S.A.. (7/29/21). "Press Release: David Allmond Announced as CEO Following Decision by Graham Mullis to Retire". Paris & Camberley....
• [3] Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley....
• [4] Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley....
• [5] Novacyt S.A.. (9/13/18). "Press Release: Novacyt Partners with Applied Microarrays in Assay Design". Paris & Camberley....
• [6] Novacyt S.A.. (4/26/18). "Press Release: Novacyt Full Year 2017 Results". Paris & Camberley....
• [7] Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge....
• [8] Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge....
• [9] Novacyt S.A.. (6/20/17). "Press Release: Novacyt Successfully Completes €3.0M Fundraising". Paris & Cambridge....
• [10] Novacyt S.A.. (4/27/17). "Press Release: Novacyt Full Year 2016 Results". Paris & Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.